Carcinoid tumor of lung and BRCA mutation: a case report

被引:1
作者
Shariff, Mohammed Z. [1 ]
Curras-Martin, Diana [1 ]
Campbell, Natasha [1 ]
Gupta, Varsha [1 ]
Mikhail, John D. [1 ]
Levitt, Michael J. [1 ]
Hossain, Mohammad A. [1 ]
机构
[1] Jersey Shore Univ, Dept Med, Med Ctr, Hackensack Meridian Hlth,Internal Med Residency P, Neptune, NJ 07753 USA
关键词
Carcinoid tumor; BRCA mutation; Infrahilar mass; RISK-FACTORS; BRONCHIAL CARCINOIDS; EPIDEMIOLOGY; SURVIVAL;
D O I
10.1186/s13256-019-2052-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background A BRCA mutation is a mutation in either of the BRCA1 or BRCA2 genes, which are tumor suppressor genes. Hundreds of different types of mutations in these genes have been identified, some of which have been determined to be harmful, whereas others have no proven impact. BRCA mutations are well known to be associated with breast, uterine, and ovarian cancers along with some nongynecological malignancies involving the peritoneum, prostate, pancreas, skin, stomach, and rectum. However, there are no reported cases to date of an association between carcinoid tumors and a BRCA mutation. Case presentation Our patient was a 33-year-old White woman with BRCA2 mutation who presented to her primary care physician for evaluation of abdominal pain. She underwent computed tomography of her abdomen and pelvis, which showed an incidental finding of infrahilar mass along with renal stones. Further workup with bronchoscopy and biopsy of the mass confirmed it to be a carcinoid tumor of the lung. Conclusions No literature thus far exists describing a connection between BRCA mutations and carcinoid tumors. Early diagnosis and prompt treatment of carcinoid tumors are proven to have impact on survival and prognosis of these patients.
引用
收藏
页数:4
相关论文
共 19 条
  • [1] Pulmonary atypical carcinoid: Predictors of survival in 106 cases
    Beasley, MB
    Thunnissen, FBJ
    Brambilla, E
    Hasleton, P
    Steele, R
    Hammar, SP
    Colby, TV
    Sheppard, M
    Shimosato, Y
    Koss, MN
    Falk, R
    Travis, WD
    [J]. HUMAN PATHOLOGY, 2000, 31 (10) : 1255 - 1265
  • [2] Characterization of BRCA1 and BRCA2 Deleterious Mutations and Variants of Unknown Clinical Significance in Unilateral and Bilateral Breast Cancer: The WECARE Study
    Borg, Ake
    Haile, Robert W.
    Malone, Kathleen E.
    Capanu, Marinela
    Diep, Ahn
    Torngren, Therese
    Teraoka, Sharon
    Begg, Colin B.
    Thomas, Duncan C.
    Concannon, Patrick
    Mellemkjaer, Lene
    Bernstein, Leslie
    Tellhed, Lina
    Xue, Shanyan
    Olson, Eric R.
    Liang, Xiaolin
    Dolle, Jessica
    Borresen-Dale, Anne-Lise
    Bernstein, Jonine L.
    [J]. HUMAN MUTATION, 2010, 31 (03) : E1200 - E1240
  • [3] Diagnostic and therapeutic management of neuroendocrine lung tumors - A clinical study of 44 cases
    Carretta, A
    Ceresoli, GL
    Arrigoni, G
    Canneto, B
    Reni, M
    Cigala, C
    Zannini, P
    [J]. LUNG CANCER, 2000, 29 (03) : 217 - 225
  • [4] Carcinoid tumors of the lung and multimodal therapy
    Divisi, D
    Crisci, R
    [J]. THORACIC AND CARDIOVASCULAR SURGEON, 2005, 53 (03) : 168 - 172
  • [5] Outcome and Prognostic Factors in Bronchial Carcinoids A Single-Center Experience
    Filosso, Pier Luigi
    Oliaro, Alberto
    Ruffini, Enrico
    Bora, Giulia
    Lyberis, Paraskevas
    Asioli, Sofia
    Delsedime, Luisa
    Sandri, Alberto
    Guerrera, Francesco
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (10) : 1282 - 1288
  • [6] Froudarakis M, 1996, ONCOLOGY-BASEL, V53, P153
  • [7] Risk factors associated with neuroendocrine tumors: A US-based case-control study
    Hassan, Manal M.
    Phan, Alexandria
    Li, Donghui
    Dagohoy, Cecile G.
    Leary, Colleen
    Yao, James C.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (04) : 867 - 873
  • [8] Neuroendocrine Tumor Epidemiology Contrasting Norway and North America
    Hauso, Oyvind
    Gustafson, Bjorn I.
    Kidd, Mark
    Waldum, Heige L.
    Drozdov, Ignat
    Chan, Anthony K. C.
    Modlin, Irvin M.
    [J]. CANCER, 2008, 113 (10) : 2655 - 2664
  • [9] Hemminki K, 2001, CANCER, V92, P2204, DOI 10.1002/1097-0142(20011015)92:8<2204::AID-CNCR1564>3.0.CO
  • [10] 2-R